Optiver Holding’s Hologic HOLX Stock Holding History

Optiver Holding’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-801	Closed	-$64.6K	–	532
2023 Q1	$64.6K	Buy	+801	New	+$64.5K	﹤0.01%	423

Other funds holding HOLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Optiver Holding's HOLX Position: Q2 2023 in Review

Optiver Holding sold out of Hologic (HOLX) in Q2 2023, closing a stake of 801 shares — an estimated $64.6K sold.

Optiver Holding first reported a position in HOLX in Q1 2023 and held it in 1 quarter. The position peaked at $64.6K in Q1 2023. 712 funds tracked by Wall St. Rank hold HOLX as of Q2 2023.

Optiver Holding reported no remaining Hologic position as of Q2 2023 after selling out during the quarter.
Optiver Holding sold 801 Hologic shares in Q2 2023, an estimated $64.6K.
Optiver Holding first reported a position in Hologic in Q1 2023 and held it in 1 quarter.
Optiver Holding's Hologic position peaked at $64.6K in Q1 2023.
712 funds tracked by Wall St. Rank held Hologic as of Q2 2023.

Based on Optiver Holding's 13F filing for Q2 2023, filed 10 Aug 2023.